Conestoga Capital Advisors LLC Increases Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Conestoga Capital Advisors LLC increased its holdings in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 12.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,521,137 shares of the company's stock after buying an additional 595,280 shares during the period. Conestoga Capital Advisors LLC owned about 4.75% of Definitive Healthcare worth $54,880,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Global Retirement Partners LLC grew its holdings in Definitive Healthcare by 86.0% during the 3rd quarter. Global Retirement Partners LLC now owns 4,171 shares of the company's stock worth $31,000 after acquiring an additional 1,928 shares during the period. Ameritas Investment Partners Inc. acquired a new stake in Definitive Healthcare during the 2nd quarter worth about $41,000. Ensign Peak Advisors Inc acquired a new stake in Definitive Healthcare during the 3rd quarter worth about $53,000. PNC Financial Services Group Inc. grew its holdings in Definitive Healthcare by 34.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the company's stock worth $56,000 after acquiring an additional 1,309 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in Definitive Healthcare by 223.1% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,710 shares of the company's stock worth $89,000 after acquiring an additional 3,943 shares during the period. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock traded down $0.13 during mid-day trading on Wednesday, hitting $7.73. 396,733 shares of the stock were exchanged, compared to its average volume of 567,950. Definitive Healthcare Corp. has a 12 month low of $5.53 and a 12 month high of $12.45. The company has a 50-day simple moving average of $8.57 and a 200 day simple moving average of $8.33. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. The company has a market capitalization of $909.98 million, a P/E ratio of -4.34, a P/E/G ratio of 11.56 and a beta of 1.39.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The company had revenue of $65.93 million for the quarter, compared to analysts' expectations of $66.01 million. Sell-side analysts anticipate that Definitive Healthcare Corp. will post 0.07 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DH has been the subject of a number of recent analyst reports. Canaccord Genuity Group increased their price target on Definitive Healthcare from $9.00 to $10.00 and gave the stock a "hold" rating in a report on Thursday, February 29th. Stifel Nicolaus reduced their target price on Definitive Healthcare from $12.00 to $11.00 and set a "buy" rating for the company in a research note on Wednesday, January 17th. Canaccord Genuity Group downgraded Definitive Healthcare from a "buy" rating to a "hold" rating in a research note on Friday, January 5th. Barclays raised their target price on Definitive Healthcare from $10.00 to $11.00 and gave the company an "equal weight" rating in a research note on Friday, March 1st. Finally, Needham & Company LLC downgraded Definitive Healthcare from a "buy" rating to a "hold" rating in a research note on Wednesday, January 17th. Seven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $11.31.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.